These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 2863837)
21. Opiate receptor supersensitivity produced by chronic naloxone treatment: dissociation of morphine-induced antinociception and conditioned taste aversion. Bardo MT; Miller JS; Risner ME Pharmacol Biochem Behav; 1984 Oct; 21(4):591-7. PubMed ID: 6095324 [TBL] [Abstract][Full Text] [Related]
22. Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats. Araki H; Kawakami KY; Jin C; Suemaru K; Kitamura Y; Nagata M; Futagami K; Shibata K; Kawasaki H; Gomita Y Psychopharmacology (Berl); 2004 Feb; 171(4):398-404. PubMed ID: 13680070 [TBL] [Abstract][Full Text] [Related]
23. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice. Shoblock JR; Maidment NT Neuropsychopharmacology; 2006 Jan; 31(1):171-7. PubMed ID: 15956992 [TBL] [Abstract][Full Text] [Related]
24. Lesions of the hypothalamic arcuate nucleus modify discrete brain and pituitary pools of dynorphin in addition to beta-endorphin in the rat. Millan MH; Millan MJ; Przewłocki R Neurosci Lett; 1984 Jul; 48(2):149-54. PubMed ID: 6148723 [TBL] [Abstract][Full Text] [Related]
25. Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands. Shippenberg TS; Herz A J Pharmacol Exp Ther; 1991 Mar; 256(3):1101-6. PubMed ID: 1848627 [TBL] [Abstract][Full Text] [Related]
26. On the relationship between clonidine hypotension and brain beta-endorphin in the spontaneously hypertensive rat: studies with alpha adrenergic and opiate blockers. Mastrianni JA; Ingenito AJ J Pharmacol Exp Ther; 1987 Jul; 242(1):378-87. PubMed ID: 3039113 [TBL] [Abstract][Full Text] [Related]
27. SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Acquas E; Carboni E; Leone P; Di Chiara G Psychopharmacology (Berl); 1989; 99(2):151-5. PubMed ID: 2572027 [TBL] [Abstract][Full Text] [Related]
28. Naloxone, adrenalectomy, and steroid replacement: evidence against a role for circulating beta-endorphin in food intake. Wallace M; Fraser CD; Clements JA; Funder JW Endocrinology; 1981 Jan; 108(1):189-92. PubMed ID: 6257484 [TBL] [Abstract][Full Text] [Related]
30. Endorphinergic and alpha-noradrenergic systems in the paraventricular nucleus: effects on eating behavior. Leibowitz SF; Hor L Peptides; 1982; 3(3):421-8. PubMed ID: 6289281 [TBL] [Abstract][Full Text] [Related]
31. Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation. Rossier J; French E; Rivier C; Shibasaki T; Guillemin R; Bloom FE Proc Natl Acad Sci U S A; 1980 Jan; 77(1):666-9. PubMed ID: 6244573 [TBL] [Abstract][Full Text] [Related]
32. Effect of chronic naltrexone and methadone administration on brain immunoreactive beta-endorphin in the rat. Ragavan VV; Wardlaw SL; Kreek MJ; Frantz AG Neuroendocrinology; 1983 Oct; 37(4):266-8. PubMed ID: 6314167 [TBL] [Abstract][Full Text] [Related]
33. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Bals-Kubik R; Herz A; Shippenberg TS Psychopharmacology (Berl); 1989; 98(2):203-6. PubMed ID: 2569217 [TBL] [Abstract][Full Text] [Related]
34. The dopamine antagonist, alpha-flupenthixol, interferes with naloxone-induced place aversion learning, but not with acute opiate dependence in rats. Santi AN; Parker LA Pharmacol Biochem Behav; 2001; 70(2-3):193-7. PubMed ID: 11701188 [TBL] [Abstract][Full Text] [Related]
35. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens. Huidobro-Toro JP; Caturay EM; Ling N; Lee NM; Loh HH; Way EL J Pharmacol Exp Ther; 1982 Jul; 222(1):262-9. PubMed ID: 6123591 [TBL] [Abstract][Full Text] [Related]
37. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Stinus L; Cador M; Zorrilla EP; Koob GF Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444 [TBL] [Abstract][Full Text] [Related]
38. The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning. Parker LA; Cyr JA; Santi AN; Burton PD Pharmacol Biochem Behav; 2002 May; 72(1-2):87-92. PubMed ID: 11900773 [TBL] [Abstract][Full Text] [Related]
39. Kappa receptors mediate the peripheral aversive effects of opiates. Bechara A; van der Kooy D Pharmacol Biochem Behav; 1987 Oct; 28(2):227-33. PubMed ID: 2825221 [TBL] [Abstract][Full Text] [Related]
40. Effect of intraventricular beta-endorphin and morphine on hypothalamic-pituitary-adrenal activity and the release of pituitary beta-endorphin. Haracz JL; Bloom AS; Wang RI; Tseng LF Neuroendocrinology; 1981 Sep; 33(3):170-5. PubMed ID: 6270585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]